malondialdehyde has been researched along with Dyslipidemia in 49 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 5 (10.20) | 29.6817 |
| 2010's | 40 (81.63) | 24.3611 |
| 2020's | 4 (8.16) | 2.80 |
| Authors | Studies |
|---|---|
| Boarescu, I; Boarescu, PM; Bocșan, IC; Bolboacă, SD; Bulboacă, AE; Buzoianu, AD; Mada, RO; Neagu, N; Pop, RM; Popa, ID; Roşian, ŞH; Rus, V | 1 |
| Abd El-Monem, AM; Ali, RH; El Agaty, SM; Galal Hamam, G; Lasheen, NN; Lebda, FM | 1 |
| Abe, S; Hashimoto, R; Hasumi, H; Hirose, S; Inoue, T; Masuyama, T; Numao, T; Sakuma, M; Toyoda, S; Waku, R; Yazawa, H | 1 |
| Bashiri, R; Ghadiri-Anari, A; Gheflati, A; Kord, MT; Nadjarzadeh, A; Reza, JZ | 1 |
| Kawai, M; Minai, K; Nagoshi, T; Ogawa, K; Ogawa, T; Tanaka, TD; Yamada, T; Yoshimura, M | 1 |
| Du, H; He, Y; Li, C; Wan, H; Wang, Y; Wang, Z; Yang, J; Zhou, H | 1 |
| Aluwong, T; Ambali, SF; Ayo, JO; Mohammed, B; Oladipo, OO | 1 |
| Moriyama, K; Takahashi, E | 1 |
| Nasanova, ON; Vengerovsky, AI; Yakimova, TV | 1 |
| Aggarwal, A; Arora, VK; Asha, K; Sharma, SB; Singal, A | 1 |
| Moriyama, K | 1 |
| Al-Okbi, SY; Elbakry, HFH; Fouda, KA; Hassan, ME; Hussein, AMS; Mahmoud, KF | 1 |
| Merugu, PL; Nutalapati, C; Usharani, P | 1 |
| Barichella, M; Cassani, E; Cazzola, R; Cestaro, B | 1 |
| Enli, Y; Fenkci, SM; Fenkci, V; Oztekin, O | 1 |
| Adams, J; Daud, ZA; Khosla, P; Osia, R; Sheyman, M; Tubie, B; Tubie, S | 1 |
| Adedeji, AL; Adedosu, OT; Adekunle, AS; Afolabi, OK; Oyewo, EB | 1 |
| Aktas, A; Cetinalp, NE; Evliyaoglu, O; Gürer, B; Ozay, R; Turkay, C; Uyar, ME; Uzar, E | 1 |
| Al-Okbi, SY; Edris, AE; Hamed, TE; Mohamed, DA | 1 |
| Biswal, N; Bobby, Z; Krishnamurthy, S; Lakshminarayanan, S; Rahul, I; Satheesh, S | 1 |
| Antropova, NV; Kustikova, IN; Moiseeva, IIa; Rodina, OP; Vodop'ianova, OA | 1 |
| Chen, P; Chen, W; Chen, Y; Dang, H; Liu, X; Tian, F; Zhang, H; Zhang, Q; Zhao, J | 1 |
| Lu, X; Nie, Y; Ren, D; Sun, Y; Yang, X; Zhao, Y | 1 |
| Cheserek, MJ; Le, G; Liu, J; Shi, Y; Wang, L; Wu, G | 1 |
| Akagi, H; Akasaka, T; Imanishi, T; Ino, Y; Kitabata, H; Komukai, K; Kubo, T; Kumiko, H; Matsuo, Y; Okumoto, Y; Orii, M; Ozaki, Y; Shimamura, K; Shiono, Y; Takarada, S; Tanaka, A; Tanimoto, T; Ueno, S; Yamaguchi, T; Yamano, T | 1 |
| Agrogiannis, G; Andrikopoulos, NK; Chiou, A; Kaliora, AC; Kalogeropoulos, N; Katsarou, AI; Papalois, A | 1 |
| Hu, Y; Liu, K; Miao, C; Ren, L; Sun, B; Yan, M; Zhang, Y | 1 |
| Guo, J; Hu, Y; Luo, Y; Ren, D; Yang, X; Zhao, Y | 1 |
| Fadieienko, G; Gridniev, O | 1 |
| Aluwong, T; Ayo, JO; Kpukple, A; Oladipo, OO | 1 |
| Klinnikova, MG; Koldysheva, EV; Lushnikova, EL; Mzhelskaya, MM; Sorokina, IV; Tolstikova, TG; Yuzhik, EI | 1 |
| Baj, Z; Błaszczyk, J; Fijałkowski, P; Rysz, J; Sierakowska-Fijałek, A; Stepień, M; Wosik-Erenbek, M | 1 |
| Chen, G; Ji, B; Li, B; Luo, Y; Tian, F; Xiao, Z; Yi, G | 1 |
| Abdalla, DS; Bertolami, MC; Botelho, PB; Castro, IA; Fioratti, CO | 1 |
| Balogun, WO; Elemile, PO; Eziyi, AK; Fadero, FF; Idogun, ES; Ogunro, PS; Oninla, SO | 1 |
| Biancini, GB; Biasi, L; Cipriani, F; Dal Vesco, AM; Deon, M; Manfredini, V; Peralba, Mdo C; Treméa, R; Vanzin, CS; Vargas, CR; Wajner, M | 1 |
| Alonso-Iglesias, E; Codoñer-Franch, P; Murria-Estal, R; Simó-Jordá, R; Tavárez-Alonso, S; Tortajada-Girbés, M | 1 |
| Azizi, F; Daneshpour, MS; Hedayati, M; Kashani Farid, MA; Shamshiri, AR; Siassi, F | 1 |
| Hilal, O; Nuriman, O; Ozgunes, H; Ozgunes, N; Oztas, YE; Sabuncuoglu, S; Selma, U; Suna, S; Unal, S; Yesim, OE | 1 |
| Hayashi, S; Taguchi, A | 1 |
| Bombardelli, E; Gupta, H; Morazzoni, P; Pawar, D; Riva, A | 1 |
| Chen, ZY; Lei, L; Li, LY; Liu, Q; Liu, SN; Shen, ZF; Zhang, N | 1 |
| Huan, Y; Li, LY; Liu, Q; Liu, SN; Shen, ZF; Sun, SJ | 1 |
| Ilić, J; Ivanišević, J; Jelić-Ivanović, Z; Kotur-Stevuljević, J; Spasić, S; Stefanović, A; Videnović-Ivanov, J; Vučinić-Mihailović, V | 1 |
| Carru, C; Deiana, L; Loriga, G; Pisanu, E; Satta, AE; Sotgia, S; Zinellu, A | 1 |
| Bayram, F; Kocer, D; Muhtaroglu, S; Ozsan, M | 1 |
| Mysliwiec, M; Pawlak, D; Pawlak, K | 1 |
| Li, K; Liu, L; Liu, S; Nussler, AK; Song, F; Sun, X; Yao, P; Zhou, S | 1 |
| El-Melegy, NT; Mohamed, NA; Sayed, MM | 1 |
8 trial(s) available for malondialdehyde and Dyslipidemia
| Article | Year |
|---|---|
The effect of apple vinegar consumption on glycemic indices, blood pressure, oxidative stress, and homocysteine in patients with type 2 diabetes and dyslipidemia: A randomized controlled clinical trial.
Topics: Acetic Acid; Adult; Biphenyl Compounds; Blood Glucose; Blood Pressure; Diabetes Mellitus, Type 2; Dyslipidemias; Female; Glycemic Index; Homeostasis; Homocysteine; Humans; Insulin; Insulin Resistance; Iran; Male; Malondialdehyde; Malus; Middle Aged; Oxidative Stress; Picrates | 2019 |
Evaluation of the effects of a standardized aqueous extract of Phyllanthus emblica fruits on endothelial dysfunction, oxidative stress, systemic inflammation and lipid profile in subjects with metabolic syndrome: a randomised, double blind, placebo contro
Topics: Aged; Double-Blind Method; Dyslipidemias; Female; Fruit; Glutathione; Humans; Inflammation; Lipid Metabolism; Lipids; Male; Malondialdehyde; Metabolic Syndrome; Middle Aged; Nitric Oxide; Oxidative Stress; Phyllanthus emblica; Plant Extracts | 2019 |
Vitamin E tocotrienol supplementation improves lipid profiles in chronic hemodialysis patients.
Topics: Aged; Antioxidants; Biomarkers; C-Reactive Protein; Cholesterol Ester Transfer Proteins; Dietary Supplements; Double-Blind Method; Dyslipidemias; Female; Humans; Inflammation Mediators; Interleukin-6; Kidney Failure, Chronic; Lipids; Male; Malondialdehyde; Michigan; Middle Aged; Oxidative Stress; Renal Dialysis; Time Factors; Tocotrienols; Treatment Outcome; Vitamins | 2013 |
Effect of atorvastatin therapy on fibrous cap thickness in coronary atherosclerotic plaque as assessed by optical coherence tomography: the EASY-FIT study.
Topics: Aged; Atorvastatin; C-Reactive Protein; Cholesterol, LDL; Coronary Artery Disease; Coronary Vessels; Dose-Response Relationship, Drug; Dyslipidemias; Female; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Lipoproteins, LDL; Macrophages; Male; Malondialdehyde; Matrix Metalloproteinase 9; Middle Aged; Plaque, Atherosclerotic; Prospective Studies; Pyrroles; Tomography, Optical Coherence | 2014 |
Simvastatin treatment prevents oxidative damage to DNA in whole blood leukocytes of dyslipidemic type 2 diabetic patients.
Topics: Adult; Aged; Aryldialkylphosphatase; C-Reactive Protein; Comet Assay; Diabetes Mellitus, Type 2; DNA Damage; Dyslipidemias; Female; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Leukocytes; Male; Malondialdehyde; Middle Aged; Oxidative Stress; Simvastatin | 2010 |
[Study of MDA-LDL by pioglitazone and pitavastatin in patients with type 2 diabetes].
Topics: Aged; Arteriosclerosis; Biomarkers; Cholesterol, LDL; Coronary Artery Disease; Diabetes Mellitus, Type 2; Disease Progression; Dyslipidemias; Female; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypoglycemic Agents; Lipoproteins, LDL; Male; Malondialdehyde; Middle Aged; Oxidative Stress; Pioglitazone; Quinolines; Risk Factors; Thiazolidinediones | 2011 |
A randomized, double-blind, placebo-controlled trial to evaluate efficacy and tolerability of an optimized botanical combination in the management of patients with primary hypercholesterolemia and mixed dyslipidemia.
Topics: Adult; Anticholesteremic Agents; C-Reactive Protein; Cholesterol; Double-Blind Method; Dyslipidemias; Female; Humans; Hypercholesterolemia; Male; Malondialdehyde; Middle Aged; Oxidative Stress; Phytotherapy; Plant Preparations; Prospective Studies; Superoxide Dismutase | 2012 |
LDL S-homocysteinylation decrease in chronic kidney disease patients undergone lipid lowering therapy.
Topics: Allantoin; Apolipoproteins B; Azetidines; Cholesterol, LDL; Drug Combinations; Dyslipidemias; Ezetimibe, Simvastatin Drug Combination; Female; Homocystine; Humans; Hypolipidemic Agents; Lipid Metabolism; Male; Malondialdehyde; Middle Aged; Oxidative Stress; Pilot Projects; Renal Insufficiency, Chronic; Simvastatin; Sulfhydryl Compounds; Uric Acid | 2012 |
41 other study(ies) available for malondialdehyde and Dyslipidemia
| Article | Year |
|---|---|
Evaluation of Oxidative Stress Biomarkers, Pro-Inflammatory Cytokines, and Histological Changes in Experimental Hypertension, Dyslipidemia, and Type 1 Diabetes Mellitus.
Topics: Animals; Biomarkers; Cytokines; Diabetes Mellitus, Type 1; Diet, High-Fat; Disease Models, Animal; Dyslipidemias; Hypertension; Male; Malondialdehyde; NG-Nitroarginine Methyl Ester; Nitric Oxide; Oxidative Stress; Rats; Streptozocin; Sulfhydryl Compounds | 2022 |
Cerium oxide nanoparticles modulate liver X receptor and short heterodimer partner, and attenuate liver steatosis and steatohepatitis in a rat model of postmenopausal obesity.
Topics: Animals; Anti-Inflammatory Agents; Antioxidants; Cerium; Dyslipidemias; Fatty Acids, Nonesterified; Female; Fibrosis; Fructose; Humans; Liver; Liver X Receptors; Malondialdehyde; Nanoparticles; Non-alcoholic Fatty Liver Disease; Obesity; Ovariectomy; Postmenopause; Rats; Transforming Growth Factor beta1; Tumor Necrosis Factor-alpha | 2022 |
Add-on ezetimibe treatment to low-dose statins vs medium-intensity statin monotherapy in coronary artery disease patients with poorly controlled dyslipidemia.
Topics: Aged; Aged, 80 and over; Antihypertensive Agents; C-Reactive Protein; Cholesterol, LDL; Coronary Artery Disease; Cross-Over Studies; Drug Therapy, Combination; Dyslipidemias; Ezetimibe; Female; Hemodynamics; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Lipid Peroxidation; Male; Malondialdehyde; Middle Aged; Oxidative Stress | 2019 |
Increase in oxidized low-density lipoprotein level according to hyperglycemia in patients with cardiovascular disease: A study by structure equation modeling.
Topics: Aged; Bayes Theorem; Body Mass Index; Cardiovascular Diseases; Cohort Studies; Diabetes Complications; Diabetes Mellitus; Dyslipidemias; Female; Humans; Hyperglycemia; Insulin; Latent Class Analysis; Lipoproteins, LDL; Male; Malondialdehyde; Middle Aged | 2020 |
Effects of Danhong injection on dyslipidemia and cholesterol metabolism in high-fat diets fed rats.
Topics: Alanine Transaminase; Animals; Aspartate Aminotransferases; Bile Acids and Salts; Cholesterol 7-alpha-Hydroxylase; Diet, High-Fat; Drugs, Chinese Herbal; Dyslipidemias; Feces; Glutathione; Hypolipidemic Agents; Lipid Metabolism; Liver; Liver X Receptors; Male; Malondialdehyde; Oxidative Stress; PPAR alpha; Rats, Sprague-Dawley; Superoxide Dismutase | 2021 |
Dyslipdemia induced by chronic low dose co-exposure to lead, cadmium and manganese in rats: the role of oxidative stress.
Topics: Animals; Cadmium; Cholesterol; Dyslipidemias; Glutathione Peroxidase; Glutathione Peroxidase GPX1; Lead; Male; Malondialdehyde; Manganese; Matrix Metalloproteinase 14; Oxidative Stress; Rats, Wistar; Triglycerides | 2017 |
Evaluation of Malondialdehyde Low-Density Lipoprotein Stratified by Low-Density Lipoprotein Cholesterol.
Topics: Cholesterol; Cholesterol, HDL; Cholesterol, LDL; Dyslipidemias; Humans; Lipoproteins, LDL; Malondialdehyde; Reference Values; Triglycerides | 2017 |
[The influence of nettle and burdock extracts in combination with different diets on dyslipidemia in diabetes mellitus model].
Topics: Animals; Arctium; Blood Glucose; Diabetes Mellitus, Experimental; Dyslipidemias; Glycated Hemoglobin; Male; Malondialdehyde; Mice; Plant Extracts; Urtica dioica | 2015 |
Dyslipidaemia & oxidative stress in patients of psoriasis: Emerging cardiovascular risk factors.
Topics: Adult; Antioxidants; Biomarkers; C-Reactive Protein; Cardiovascular Diseases; Dyslipidemias; Female; Glutathione; Humans; Lipid Peroxidation; Lipids; Lipoproteins, LDL; Male; Malondialdehyde; Middle Aged; Oxidative Stress; Psoriasis; Risk Factors; Superoxide Dismutase | 2017 |
Low-density Lipoprotein Subclasses are Associated with Serum Uric Acid Levels.
Topics: Adult; Aged; Body Mass Index; Cholesterol, HDL; Cholesterol, LDL; Diabetes Mellitus; Dyslipidemias; Female; Humans; Hyperuricemia; Lipoproteins, LDL; Male; Malondialdehyde; Middle Aged; Renal Insufficiency, Chronic; Uric Acid; Waist Circumference | 2018 |
Health Benefits of Fennel, Rosemary Volatile Oils and their Nano-Forms in Dyslipidemic Rat Model.
Topics: Animals; Antioxidants; Catalase; Dietary Supplements; Disease Models, Animal; Dyslipidemias; Foeniculum; Lipid Peroxidation; Liver; Male; Malondialdehyde; Oils, Volatile; Oxidative Stress; Plant Oils; Rats; Rosmarinus | 2018 |
Impaired fluidity and oxidizability of HDL hydrophobic core and amphipathic surface in dyslipidemic men.
Topics: Adult; Body Mass Index; Cardiovascular Diseases; Chemical Phenomena; Dyslipidemias; Humans; Hydrophobic and Hydrophilic Interactions; Italy; Kinetics; Lipid Peroxidation; Lipoproteins, HDL; Male; Malondialdehyde; Membrane Fluidity; Middle Aged; Obesity; Overweight; Oxidation-Reduction; Risk; Surface Properties | 2013 |
Serum Fetuin-A levels, insulin resistance and oxidative stress in women with polycystic ovary syndrome.
Topics: Adolescent; Adult; alpha-2-HS-Glycoprotein; Androgens; Blood Glucose; Dyslipidemias; Female; Follicle Stimulating Hormone; Glutathione; Humans; Hyperandrogenism; Insulin; Insulin Resistance; Luteinizing Hormone; Malondialdehyde; Oxidative Stress; Peroxidase; Polycystic Ovary Syndrome; Sex Hormone-Binding Globulin; Superoxide Dismutase; Young Adult | 2013 |
Oxidative indices correlate with dyslipidemia and pro-inflammatory cytokine levels in fluoride-exposed rats.
Topics: Administration, Oral; Animals; Aryldialkylphosphatase; Cardiovascular Diseases; Cytokines; Dyslipidemias; Fluorides; Lipid Metabolism; Male; Malondialdehyde; Rats; Toxicity Tests, Chronic | 2013 |
The role of oxidative stress and inflammatory response in high-fat diet induced peripheral neuropathy.
Topics: Animals; Biomarkers; Blood Glucose; Cytokines; Diet, High-Fat; Dyslipidemias; Inflammation; Lipids; Male; Malondialdehyde; Oxidative Stress; Peripheral Nervous System Diseases; Rats; Rats, Wistar | 2014 |
Protective effect of clove oil and eugenol microemulsions on fatty liver and dyslipidemia as components of metabolic syndrome.
Topics: Administration, Oral; Animals; Cholesterol; Clove Oil; Dose-Response Relationship, Drug; Dyslipidemias; Emulsions; Eugenol; Fatty Liver; Liver; Liver Diseases; Male; Malondialdehyde; Metabolic Syndrome; Nanoparticles; Particle Size; Rats; Rats, Sprague-Dawley; Triglycerides; Tumor Necrosis Factor-alpha | 2014 |
Brachial artery flow-mediated dilatation and carotid intima medial thickness in pediatric nephrotic syndrome: a cross-sectional case-control study.
Topics: Adolescent; Body Mass Index; Brachial Artery; Carotid Intima-Media Thickness; Case-Control Studies; Child; Child, Preschool; Cross-Sectional Studies; Dyslipidemias; Female; Humans; Infant; Lipid Metabolism; Male; Malondialdehyde; Nephrotic Syndrome; Oxidative Stress; Vasodilation | 2015 |
[The influence of cytoflavin and cardioxipin on the indices of lipid peroxidation and antioxidant protection in the blood of rat with dyslipidemia].
Topics: Animals; Animals, Outbred Strains; Antioxidants; Catalase; Drug Combinations; Dyslipidemias; Erythrocytes; Female; Flavin Mononucleotide; Inosine Diphosphate; Lipid Peroxidation; Male; Malondialdehyde; Niacinamide; Protective Agents; Pyridones; Rats; Succinates; Superoxide Dismutase | 2014 |
Antidiabetic effect of Lactobacillus casei CCFM0412 on mice with type 2 diabetes induced by a high-fat diet and streptozotocin.
Topics: Animals; Antioxidants; Blood Glucose; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 2; Diet, High-Fat; Dyslipidemias; Endotoxins; Glucose Intolerance; Glycated Hemoglobin; Hypoglycemic Agents; Insulin; Islets of Langerhans; Lacticaseibacillus casei; Lipids; Male; Malondialdehyde; Mice, Inbred C57BL; Oxidative Stress; Streptozocin; Tumor Necrosis Factor-alpha | 2014 |
Chemical composition of Pleurotus eryngii polysaccharides and their inhibitory effects on high-fructose diet-induced insulin resistance and oxidative stress in mice.
Topics: Animals; Antioxidants; Blood Glucose; Chromatography, High Pressure Liquid; Disease Models, Animal; Dyslipidemias; Fatty Liver; Fructose; Galactose; Glucose; Glutathione Peroxidase; Hyperglycemia; Hyperinsulinism; Insulin; Insulin Resistance; Lipid Peroxidation; Liver; Male; Malondialdehyde; Mannose; Mice; Oxidative Stress; Pleurotus; Polysaccharides; Superoxide Dismutase | 2014 |
[Comparison of serum lipid and protein oxidation products levels in patients with different types of dyslipidemia].
Topics: Antioxidants; Case-Control Studies; Dyslipidemias; Humans; Hyperlipidemias; Hypertriglyceridemia; Lipids; Lipoproteins, HDL; Malondialdehyde; Oxidation-Reduction; Oxidative Stress; Triglycerides | 2014 |
Amelioration of oxidative and inflammatory status in hearts of cholesterol-fed rats supplemented with oils or oil-products with extra virgin olive oil components.
Topics: alpha-Tocopherol; Animals; Cholesterol, Dietary; Cholesterol, HDL; Cholesterol, LDL; Diet; Diet, High-Fat; Dyslipidemias; Fatty Acids; Glutathione; Hypercholesterolemia; Inflammation; Interleukin-6; Male; Malondialdehyde; Olive Oil; Oxidative Stress; Phenols; Plant Oils; Rats; Rats, Wistar; Sitosterols; Sunflower Oil; Triglycerides; Tumor Necrosis Factor-alpha | 2016 |
Icariin Attenuates High-cholesterol Diet Induced Atherosclerosis in Rats by Inhibition of Inflammatory Response and p38 MAPK Signaling Pathway.
Topics: Animals; Anticholesteremic Agents; Atherosclerosis; Cholesterol; Cholesterol, HDL; Cholesterol, LDL; Diet, High-Fat; Disease Models, Animal; Down-Regulation; Drugs, Chinese Herbal; Dyslipidemias; Flavonoids; Inflammation; Interleukin-6; Lipids; Male; Malondialdehyde; MAP Kinase Signaling System; Oxidative Stress; p38 Mitogen-Activated Protein Kinases; Rats; Rats, Wistar; RNA, Messenger; Simvastatin; Superoxide Dismutase; Triglycerides; Tumor Necrosis Factor-alpha | 2016 |
Hypoglycemic and hepatoprotective effects of D-chiro-inositol-enriched tartary buckwheat extract in high fructose-fed mice.
Topics: Alanine Transaminase; Animals; Aspartate Aminotransferases; Blood Glucose; C-Reactive Protein; Chemical and Drug Induced Liver Injury; Cholesterol; Cholesterol, LDL; Dose-Response Relationship, Drug; Dyslipidemias; Fagopyrum; Fatty Liver; Fructose; Glutathione Peroxidase; Hyperglycemia; Hyperinsulinism; Hypoglycemic Agents; Inositol; Insulin; L-Lactate Dehydrogenase; Liver; Male; Malondialdehyde; Mice; Oxidative Stress; Plant Extracts; Superoxide Dismutase; Triglycerides | 2015 |
[FEATURES MANIFESTATIONS COMORBID CURRENTS OF GASTROESOPHAGEAL REFLUX DISEASE AND ARTERIAL HYPERTENSION DEPENDING ON THE DEGREE OF ARTERIAL HYPERTENSION].
Topics: Apelin; Blood Pressure; Blood Pressure Monitoring, Ambulatory; Case-Control Studies; Circadian Rhythm; Dyslipidemias; Echocardiography; Esophagus; Female; Gastroesophageal Reflux; Glutathione Peroxidase; Humans; Hydrogen-Ion Concentration; Hypertension; Lipid Peroxidation; Male; Malondialdehyde; Middle Aged; Nitrites; Oxidative Stress; Severity of Illness Index; Ventricular Remodeling | 2015 |
Amelioration of Hyperglycaemia, Oxidative Stress and Dyslipidaemia in Alloxan-Induced Diabetic Wistar Rats Treated with Probiotic and Vitamin C.
Topics: Animals; Antioxidants; Ascorbic Acid; Blood Glucose; Diabetes Mellitus, Experimental; Dyslipidemias; Hyperglycemia; Insulin; Lipid Peroxidation; Male; Malondialdehyde; Oxidative Stress; Probiotics; Random Allocation; Rats; Rats, Wistar | 2016 |
Cardiotoxic and Dyslipidemic Effects of Doxorubicin and Betulinic Acid Amide.
Topics: Amides; Animals; Antibiotics, Antineoplastic; Antineoplastic Agents, Phytogenic; Betulinic Acid; Body Weight; Cardiotoxicity; Catalase; Cell Size; Cholesterol, HDL; Cholesterol, LDL; Doxorubicin; Drug Combinations; Dyslipidemias; Male; Malondialdehyde; Myocardium; Myocytes, Cardiac; Organ Size; Pentacyclic Triterpenes; Rats; Rats, Wistar; Triglycerides; Triterpenes | 2016 |
[Estimation of selected parameters antioxidant barrier and lipid parameters in children with atherosclerosis risk factors].
Topics: Adolescent; Antioxidants; Atherosclerosis; Biomarkers; Catalase; Causality; Cholesterol; Cholesterol, HDL; Cholesterol, LDL; Comorbidity; Dyslipidemias; Female; Glutathione Peroxidase; Humans; Hypertension; Lipid Metabolism; Male; Malondialdehyde; Obesity; Reactive Oxygen Species; Risk Factors; Superoxide Dismutase; Triglycerides | 2008 |
Dietary intervention with AHP, a functional formula diet, improves both serum and hepatic lipids profile in dyslipidemia mice.
Topics: Analysis of Variance; Animals; Antioxidants; Basidiomycota; Body Weight; Cholates; Cholesterol; Complex Mixtures; Crataegus; Drugs, Chinese Herbal; Dyslipidemias; Fatty Liver; Hydroxymethylglutaryl CoA Reductases; Lipids; Liver; Male; Malondialdehyde; Medicine, Traditional; Mice; Nitric Oxide; Organ Size; Plant Extracts; Pueraria; Random Allocation; Superoxide Dismutase | 2009 |
Classification of individuals with dyslipidaemia controlled by statins according to plasma biomarkers of oxidative stress using cluster analysis.
Topics: Aged; Biomarkers; Biphenyl Compounds; Blood Glucose; Cluster Analysis; Diet; Dyslipidemias; Fatty Acids; Female; Humans; Lipoproteins; Lipoproteins, LDL; Male; Malondialdehyde; Middle Aged; Oxidative Stress; Picrates | 2010 |
Plasma lipid peroxidation and totalantioxidant status among dyslipidaemic and hypertensive Nigerians with high risk of coronary heart disease.
Topics: Antioxidants; Case-Control Studies; Cholesterol, HDL; Cholesterol, LDL; Coronary Artery Disease; Dyslipidemias; Female; Free Radicals; Humans; Hypertension; Lipid Peroxidation; Male; Malondialdehyde; Middle Aged; Nigeria; Risk Factors; Statistics as Topic; Triglycerides | 2009 |
Elevated advanced oxidation protein products (AOPPs) indicate metabolic risk in severely obese children.
Topics: Adolescent; Age of Onset; Biomarkers; Chi-Square Distribution; Child; Dinoprost; Dyslipidemias; Female; Humans; Hypertension; Insulin Resistance; Linear Models; Lipid Peroxidation; Lipids; Male; Malondialdehyde; Metabolic Syndrome; Obesity; Oxidation-Reduction; Oxidative Stress; Proteins; Risk Assessment; Risk Factors; Severity of Illness Index; Spain; Spectrophotometry; Sulfhydryl Compounds; Thiobarbituric Acid Reactive Substances; Up-Regulation | 2012 |
Association between CETP Taq1B and LIPC -514C/T polymorphisms with the serum lipid levels in a group of Tehran's population: a cross sectional study.
Topics: Adult; Aged; Aged, 80 and over; Cholesterol Ester Transfer Proteins; Cholesterol, HDL; Cohort Studies; Cross-Sectional Studies; Dyslipidemias; Female; Gene Frequency; Genetic Association Studies; Heterozygote; Humans; Iran; Lipase; Lipids; Male; Malondialdehyde; Middle Aged; Polymorphism, Restriction Fragment Length; Polymorphism, Single Nucleotide; Promoter Regions, Genetic; Site-Specific DNA-Methyltransferase (Adenine-Specific); Vascular Diseases | 2010 |
Hypocholesterolemia is associated negatively with hemolysate lipid peroxidation in sickle cell anemia patients.
Topics: Adolescent; Anemia, Sickle Cell; Child; Child, Preschool; Cholesterol; Dyslipidemias; Female; Hemolysis; Humans; Lipid Peroxidation; Male; Malondialdehyde; Oxidative Stress | 2011 |
[A dyslipidemia animal model induced by poloxamer 407 in golden hamsters and pilot study on the mechanism].
Topics: Animals; Anticholesteremic Agents; Atorvastatin; CD36 Antigens; Cricetinae; Disease Models, Animal; Dyslipidemias; Fenofibrate; Heptanoic Acids; Hydroxymethylglutaryl CoA Reductases; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypolipidemic Agents; Lipid Metabolism; Liver; Male; Malondialdehyde; Mesocricetus; Nitric Oxide; Phosphatidylcholine-Sterol O-Acyltransferase; Poloxamer; PPAR alpha; Pyrroles; RNA, Messenger; Superoxide Dismutase | 2011 |
Long-term fenofibrate treatment impaired glucose-stimulated insulin secretion and up-regulated pancreatic NF-kappa B and iNOS expression in monosodium glutamate-induced obese rats: is that a latent disadvantage?
Topics: Adenosine Triphosphatases; Animals; Blood Glucose; Dyslipidemias; Fenofibrate; Glucose; Homeostasis; Insulin; Insulin Secretion; Malondialdehyde; Mitochondria; NF-kappa B; Nitric Oxide Synthase Type II; Obesity; Pancreas; Protein Transport; Rats; Rats, Wistar; Sodium Glutamate; Time Factors; Up-Regulation | 2011 |
Dyslipidemia and oxidative stress in sarcoidosis patients.
Topics: Adult; Antioxidants; Case-Control Studies; Dyslipidemias; Erythrocytes; Female; Glutathione Peroxidase; Humans; Lipid Peroxidation; Lipids; Male; Malondialdehyde; Middle Aged; Oxidative Stress; Sarcoidosis; Superoxide Dismutase; Superoxides; Triglycerides | 2012 |
Evaluation of endothelial dysfunction, lipid metabolism in women with polycystic ovary syndrome: relationship of paraoxonase 1 activity, malondialdehyde levels, low-density lipoprotein subfractions, and endothelial dysfunction.
Topics: Adolescent; Apolipoprotein A-I; Apolipoproteins B; Aryldialkylphosphatase; Cardiovascular Diseases; Dyslipidemias; Endothelin-1; Endothelium, Vascular; Female; Humans; Insulin Resistance; Lipoproteins, LDL; Malondialdehyde; Nitric Oxide; Oxidative Stress; Polycystic Ovary Syndrome; Risk Factors; Testosterone; Turkey; Young Adult | 2012 |
Oxidized low-density lipoprotein (oxLDL) plasma levels and oxLDL to LDL ratio - are they real oxidative stress markers in dialyzed patients?
Topics: Analysis of Variance; Biomarkers; C-Reactive Protein; Cross-Sectional Studies; Data Interpretation, Statistical; Dyslipidemias; Enzyme-Linked Immunosorbent Assay; Female; Humans; Lipoproteins, LDL; Male; Malondialdehyde; Middle Aged; Oxidation-Reduction; Oxidative Stress; Regression Analysis; Renal Dialysis; Superoxide Dismutase; Uremia | 2013 |
Ginkgo biloba extract prevents ethanol induced dyslipidemia.
Topics: Animals; Central Nervous System Depressants; Cholesterol; Disease Models, Animal; Dose-Response Relationship, Drug; Drugs, Chinese Herbal; Dyslipidemias; Ethanol; Ginkgo biloba; Hyperlipidemias; Lipid Metabolism; Male; Malondialdehyde; Phytotherapy; Random Allocation; Rats; Rats, Sprague-Dawley; Triglycerides | 2007 |
Oxidative modification of low-density lipoprotein in relation to dyslipidemia and oxidant status in children with steroid sensitive nephrotic syndrome.
Topics: Antioxidants; Apolipoprotein A-I; Apolipoproteins B; Child; Child, Preschool; Cholesterol, HDL; Cholesterol, LDL; Dyslipidemias; Female; Glutathione Peroxidase; Humans; Lipoproteins, LDL; Male; Malondialdehyde; Nephrotic Syndrome; Oxidants; Oxidative Stress; Recurrence; Serum Albumin; Steroids | 2008 |